The SC Translational Research Institute:
Where Scientists and Healthcare Providers Connect to Improve the Health of Americans
The South Carolina Translational Research Institute is an exciting initiative at MUSC. Directed by Dr. Kathleen Brady, the goal of SCTR is to provide resources to ensure that scientific research actually improves the everyday healthcare of Americans. In this podcast, Dr. Brady explains how SCTR provides support for researchers to translate ‘great ideas’ into great science – and to facilitate dialogue between scientists and doctors so that ‘great science’ is translated into optimal medical care. Dr. Brady uses the example of addiction research: basic science researchers may develop medicines to control cravings, but the critical next step is to address practical issues that could prevent clinicians from adopting new therapies.
Dr. Brady is Director of the Clinical Neuroscience Division, the Women’s Research Center, the General Clinical Research Center (GCRC), Principal Investigator of the Southern Consortium of NIDA’s Clinical Trials Network, and Associate Dean for Clinical Research. Dr. Brady’s research is devoted to the study of drug and alcohol abuse/addiction and comorbid conditions such as posttraumatic stress disorder and other anxiety disorders. Her areas of specialty include addiction and comorbidity, gender and women’s issues related to addiction, stress, and hypothalamic-pituitary-adrenal axis functioning in substance-dependent individuals. Dr. Brady’s recent research includes an interest in the interface between basic and clinical science investigating the mechanistic connection between stress and substance use disorders and in the translation of empirically-based treatments from academic medical centers to front-line treatment settings.
| Related Podcast:|
SCTR: Applying Research to the Clinical Settings (mp3)